Global HIV Therapeutics Market Analysis to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
Released On 9th June 2015
Global HIV Therapeutics Market Analysis to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline.
The HIV therapeutic market report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada. The report discusses the global pipeline for all the HIV molecules across various stages of development.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. The authors found that the HIV therapeutics market in the top seven markets was valued at $14.3 billion in 2012 and is projected to witness HIV therapeutics market growth of 1.9% during the 2012–2019 forecast period to reach $16.3 billion.
Scope
The report analyzes treatment usage patterns, drug types available and pipeline and market forecasts across indications for HIV. The Global HIV Therapeutics Market Analysis report covers and includes -
A brief introduction to HIV, including the symptoms, pathogenesis, risk factors and diagnosis
In-depth analysis of major glucose-lowering drugs for HIV, including analyses of their safety, efficacy, treatment patterns, strengths/weaknesses and
overall commercial prospects. Includes a heat map...